Core Insights - On October 24, 2025, United Imaging Healthcare (688271) closed at 142.16 CNY, up 1.54% with a trading volume of 41,800 lots and a transaction value of 594 million CNY [1] - The net inflow of main funds was 26.49 million CNY, accounting for 4.46% of the total transaction value, while retail investors experienced a net outflow of 15.47 million CNY, representing 2.60% of the total transaction value [1][2] Financial Performance - For the first half of 2025, United Imaging reported a main revenue of 6.016 billion CNY, a year-on-year increase of 12.79%, and a net profit attributable to shareholders of 998 million CNY, up 5.03% [3] - The second quarter of 2025 saw a single-quarter main revenue of 3.538 billion CNY, an 18.6% year-on-year increase, and a net profit of 628 million CNY, up 6.99% [3] - The company’s gross margin stood at 47.93%, while the net margin was 16.42% [3] Market Position - United Imaging's total market capitalization is 117.162 billion CNY, ranking second in the medical device industry, with a net asset of 20.787 billion CNY, ranking third [3] - The company has a price-to-earnings ratio (P/E) of 58.7, which is lower than the industry average of 103.78, indicating a relatively favorable valuation [3] Analyst Ratings - In the past 90 days, 24 institutions have rated the stock, with 19 buy ratings and 5 hold ratings, and the average target price set at 171.35 CNY [4]
股票行情快报:联影医疗(688271)10月24日主力资金净买入2648.53万元